Atlas Trials

Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Clinical trial NCT07133815 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07133815
Sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Homozygous Familial Hypercholesterolemia
Start date
2025-08-01
Primary completion
2025-12-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.